Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma

Research output: Working paper › Preprint

Access to Document

@techreport{c34f9ceefcf44afea408ca3f29e9180f,

title = "Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma",

author = "Wood, \{Megan L.\} and Fanburg-Smith, \{Julie C.\} and Brian, \{James M.\} and Jason White and Jonathan Powell and Andrew Freiberg",

year = "2023",

month = jan,

day = "23",

doi = "10.22541/au.167446811.16950189/v1",

language = "English",

publisher = "Authorea",

address = "United States",

type = "WorkingPaper",

institution = "Authorea",

}

TY - UNPB

T1 - Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma

AU - Wood, Megan L.

AU - Fanburg-Smith, Julie C.

AU - Brian, James M.

AU - White, Jason

AU - Powell, Jonathan

AU - Freiberg, Andrew

PY - 2023/1/23

Y1 - 2023/1/23

UR - https://doi.org/10.22541/au.167446811.16950189/v1

U2 - 10.22541/au.167446811.16950189/v1

DO - 10.22541/au.167446811.16950189/v1

M3 - Preprint

BT - Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma

PB - Authorea

ER -